<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

MENA (Middle East and North Africa)

Healthcare market research experts with the local knowledge and experience to help you maximise your competitive advantage

MENA is comprised of many countries in the North of Africa and Middle East including Algeria, Egypt, Israel, Kingdom of Saudi Arabia, South Africa and United Arab Emirates.

Almost two-thirds of the 3,300 hospitals in the region are government-owned, with the majority of these facilities found in Egypt, KSA, Algeria, and Morocco. The public sector is responsible for 64% of regional healthcare expenditure – however this proportion is shrinking as more private companies enter the market, driven by government attempts to attract private enterprise.

Vast differences across the region make it unrealistic to use one proxy for the entire region, however the MENA countries do cluster into smaller groups. The six Gulf Cooperation Council (GCC) countries of Bahrain, Kuwait, Oman, Qatar, KSA, and UAE have similarities in terms of healthcare systems, culture and language. KSA is often used to represent these countries as it represents the biggest market by far. There are cultural and language similarities in the Mahgreb (North Africa) although Algeria is more focused on the public healthcare system. In the Levant (Eastern Mediterranean), Israel’s universal healthcare system is unique within the region, while Jordan is more similar to KSA.

Our emerging markets team has considerable expertise in MENA having conducted over 60 projects in 13 Middle Eastern and Northern African and can support you with your market research needs. 

MENA resources:

RP EM Experience - EE MEA_v1


Experience in Eastern Europe and MENA.


Going for growth in emerging markets (Oct 2017)


Conducting effective market research in emerging markets. 


MENA mental health article


Mental health in the MENA region.

Find out more



Request more information on Emerging Markets

Marc Yates

Marc Yates

Senior Director Asia Pacific and Emerging Markets

Marc is head of RP's dedicated Emerging Markets division. He has 35 years’ experience of market research, and has specialized in healthcare research since 1996. Marc spent 15 years in Asia, including postings in Shanghai, Hong Kong and Singapore. In 2012 he relocated back to London working closely with pharma companies looking to maximise their ROI in emerging markets. Marc is a regular speaker at industry events and has presented papers on Emerging Markets at EphMRA and PBIRG conferences.